About 1,126,700 results

Bacterial cocktail, spores counter recurrent C. diff
Jim Kling

May 22nd, 2022 - SAN DIEGO – A novel combination of eight human commensal bacteria has shown efficacy in preventing recurrent Clostridioides difficile infections in high-risk populations. The cocktail of bacterial strains (VE303), produced under tightly-controlled conditions, is delivered in powdered form over a period of 14 days.

Treatment for alcohol abuse reduces hepatitis readmission
Laird Harrison

May 22nd, 2022 - SAN DIEGO – Treating people with alcoholic hepatitis for alcohol abuse may reduce their risk of hospital readmission, researchers reported. In a retrospective analysis of nationwide data, 7.

Ingestible sensor-enabled Truvada®, taken as pre-exposure prophylaxis against HIV infection, identifies patterns of medication taking that may lead to risk of prophylactic failure in near real-time.

May 22nd, 2022 - Friday, May 20, 2022 (San Diego, U.S.)—Research from the University of California released in Clinical Infectious Diseases demonstrates that ingestible sensor-enabled Truvada®, taken as pre-exposure prophylaxis to prevent HIV infection (PrEP), can reveal patterns of medication taking behavior that may put persons at risk of prophylactic failure. The FDA-approved system, consisting of an ingesti...

Liver transplants from drug overdose deaths rose sharply during COVID-19 pandemic

May 22nd, 2022 - San Diego, CA (May 22, 2022) — Liver transplants from drug overdose donors rose significantly in the pandemic’s first year, helping keep the number of liver transplants in the U.S. stable despite COVID-19 disruptions, according to a study to be presented at Digestive Disease Week® (DDW) 2022. “When the pandemic began, we saw no decline in liver transplants, which seemed surprising since many su...

Alcohol may be more risky to the heart than previously thought

May 22nd, 2022 - Madrid, Spain – 22 May 2022: Levels of alcohol consumption currently considered safe by some countries are linked with development of heart failure, according to research presented at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1 “This study adds to the body of evidence that a more cautious approach to alcohol consumption is needed,” said study author D...

Taste buds can adapt to low salt diet

May 22nd, 2022 - Madrid, Spain – 22 May 2022: A taste adaptation intervention lowers salt intake and increases enjoyment of a sodium restricted diet in patients with hypertension, according to a small study presented at ACNAP-EuroHeartCare Congress 2022, a scientific congress of the European Society of Cardiology (ESC).1 “One of the major barriers to sticking to a low salt diet is that people do not like the ta...

Cannabis users require more sedation for endoscopy

May 21st, 2022 - Bethesda, MD (May 21, 2022) — Patients who use cannabis required higher levels of sedation during gastric endoscopies than non-users, according to research to be presented at Digestive Disease Week® (DDW) 2022. As cannabis is legalized in more places and usage rises, clinicians should be aware of patients’ habits and prepare themselves and their patients for increased sedation and accompanying ...

Speech analysis app predicts worsening heart failure before symptom onset

May 21st, 2022 - Madrid, Spain – 21 May 2022: A voice analysis app used by heart failure patients at home recognises fluid in the lungs three weeks before an unplanned hospitalisation or escalation in outpatient drug treatment. The late breaking research is presented at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1 “The current standard of care just isn’t good enough fo...

Voice-Analysis App Promising as Early Warning System for Heart Failure Decompensation

May 21st, 2022 - A voice can carry a long distance, but in patients with heart failure (HF) a voice can also carry otherwise hidden signs useful for predicting short-term risk for worsening disease, even acute decompensation. Potentially, it only has to reach a smartphone to do it, suggests a preliminary study of a mobile app designed to alert patients and clinicians to such looming HF events, if possible in ti...

CRC Screening: Blood Test Accuracy Compared to Colonoscopy

May 21st, 2022 - The first prospective study to evaluate the accuracy of a blood test for people being screened for colorectal cancer (CRC) revealed a high sensitivity and specificity. At 90% specificity, the blood assay (Guardant Health) was 100% sensitive for detecting CRC. At 95% specificity, sensitivity was 88%. The blood assay detects circulating tumor DNA from cancer in the bloodstream, which is then anal...

Being unmarried is associated with a higher risk of death in heart failure patients

May 21st, 2022 - Madrid, Spain – 21 May 2022: Unmarried heart failure patients appear less confident in managing their condition and more socially limited compared to their married counterparts, according to research presented today at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1 These differences may have contributed to the worse long-term survival observed in unmarri...

SCAI announces Early Career Research Grants

May 21st, 2022 - ATLANTA (May 21, 2022) – Today during the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions in Atlanta, SCAI President Sunil V. Rao, MD, FSCAI, announced the establishment of the SCAI Early Career Research Grants. As cardiovascular disease (CVD) morbidity and mortality in the United States continues to rise, federal funding dedicated to CVD research has rema...

Effects of COVID-19 contamination on the thyroid gland are still present after one year, study finds

May 21st, 2022 - European Society of Endocrinology Starling House, 1600 Bristol Parkway North, Bristol, BS34 8YU, UK Tel +44 1454 642247 info@euro-endo.org www.ese-hormones.org President Martin Reincke Munich, Germany. President-elect Jérôme Bertherat Paris, France. Secretary Mónica Marazuela Madrid, Spain. Treasurer Djuro Macut Belgrade, Serbia. Executive Committee members: Philippe Chanson Paris, France. Mirj...

Gender Affirming Hormone Therapy has a positive impact on well-being

May 21st, 2022 - New evidence shows that people who have undergone Gender Affirming Hormone Therapy report high grades of satisfaction with both the physical and psychological effects. A new study on this topic, carried out by researchers in Portugal, will be presented today (21 May 2022) at the 24th European Congress of Endocrinology in Milan, Italy. Gender Affirming Hormone Therapy (GAHT) aims to align the ch...

Air pollution linked to deadly heart rhythm disorder

May 21st, 2022 - Madrid, Spain – 21 May 2022: Life-threatening arrhythmias are more common on days with highly polluted air, according to research presented today at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1 The study was conducted in patients with an implantable cardioverter defibrillator (ICD), enabling the authors to track the occurrence of arrhythmias and delive...

20th anniversary and history of cosmetic botulinum toxin type A
Naissan O. Wesley, MD

May 20th, 2022 - Historical food-borne outbreaks of botulism and identification of Clostridium botulinum as the bacterium responsible have had an enormous impact in medicine related to its therapeutic and cosmetic uses. The timeline of botulinum toxin discovery began with deadly outbreaks related to contaminated food across Europe in the late 1700s, the largest of which occurred in 1793 in Wildebrad, in souther.

The anxious patient needs psychosomatic primary care
Horst Gross, MD

May 20th, 2022 - A balance between fear and relaxation is normal. However, mental dispositions and the continuous influence of environmental stimuli can disrupt this balance.

Trade-offs doctors make to become mothers: Interview study
Marcia Frellick

May 20th, 2022 - Qualitative interviews with a group of female physicians identified several concerns about fertility and family planning and how those concerns affected their career choices. Among the findings in a new study were that all 16 women interviewed said medical school education surrounding fertility was inadequate.

European committee recommends approval of baricitinib for severe alopecia areata
Doug Brunk

May 20th, 2022 - The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of baricitinib, a Janus kinase (JAK) inhibitor, for the treatment of adults with severe alopecia areata (AA). The development, which was announced in a May 20, 2022, press release from the manufacturer, Eli Lilly and Incyte, marks the first step toward European regulatory approva.

Climate change, medical education, and dermatology
Misha Rosenbach, MD

May 20th, 2022 - The recent article on including the impact of climate on health in medical education programs shines an important light on the challenge – and urgent need – of integrating climate change training into medical education. These nascent efforts are just getting underway across the country, with some programs – notably Harvard’s C-CHANGE (Center for Climate, Health, and the Global Environment) prog.